Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.
D000818:Animals; D002395:Catecholamines / Q000502:physiology; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000096:biosynthesis*; D006145:Guanethidine / Q000494:pharmacology*; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D010546:Perphenazine / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000378:metabolism; D011388:Prolactin / Q000096:biosynthesis*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014316:Tritium
D002395:Catecholamines; D014316:Tritium; D012110:Reserpine; D011388:Prolactin; D013006:Growth Hormone; D010293:Pargyline; D007490:Iproniazid; D010546:Perphenazine; D007930:Leucine; D004298:Dopamine; D006145:Guanethidine